TELFAST 180 Milligram Film Coated Tablet
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
07-06-2024
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
FEXOFENADINE HYDROCHLORIDE
Inapatikana kutoka:
Profind Wholesale Ltd
INN (Jina la Kimataifa):
FEXOFENADINE HYDROCHLORIDE
Kipimo:
180 Milligram
Dawa fomu:
Film Coated Tablet
Dawa ya aina:
Product subject to prescription which may be renewed (B)
Idhini hali ya:
Withdrawn
Idhini ya tarehe:
2013-05-02
Tabia za bidhaa
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Telfast 180 mg film-coated tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 180 mg of fexofenadine hydrochloride, which is equivalent to 168 mg of fexofenadine.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film Coated Tablet
_Product imported from Hungary:_
Peach capsule shaped tablet debossed with “018” on one side and “e” on the other side.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Relief of symptoms associated with chronic idiopathic urticaria.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
_ADULTS AND CHILDREN AGED 12 YEARS AND OVER_
The recommended dose of fexofenadine hydrochloride for adults and children aged 12 years and over is 180 mg once
daily taken before a meal.
Fexofenadine is a pharmacologically active metabolite of terfenadine.
_CHILDREN UNDER 12 YEARS OF AGE_
The efficacy and safety of fexofenadine hydrochloride has not been studied in children under 12.
_SPECIAL RISK GROUPS_
Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust
the dose of fexofenadine hydrochloride in these patients.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
As with most new drugs there is only limited data in the elderly and renally or hepatically impaired patients.
Fexofenadine hydrochloride should be administered with care in these special groups.
Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a drug class, have
been associated with the adverse events, tachycardia and palpitations _(see section 4.8)._
IRISH MEDICINES BOARD
______________________________
Soma hati kamili
